BioSpace News Archive

Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock.

Pivot Bio , agriculture’s leading nitrogen innovator, joins the Agriculture Innovation Mission for Climate ( AIM for Climate ) as an Innovation Sprint Partner, committing at least $291 million in product development funding over four years to accelerate the adoption of climate-resilient microbial nitrogen fertilizers.

CareDx Leads Scientific Evidence with Over 100 Peer-Reviewed Publications Supporting the Clinical Use of AlloSure and AlloMap for Organ Transplant Patients.

Kyverna Therapeutics today announced the clearance of its first Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial of KYV-101, a novel therapy for the treatment of lupus nephritis.

Nemaura Medical, Inc. announces today that CEO Dr. Faz Chowdhury will present a corporate overview at at the Bernstein 2nd Annual CGM Disruptors Conference which is being held virtually on November 18, 2022.